CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-04 | Montagut Etienne Chief Business Officer | Grant or award | +21,645 | 120,225 | ||
| 2024-03-04 | Niedzwiecki Daniel See Remarks | Grant or award | +6,466 | 103,217 | ||
| 2024-03-04 | Sabens Andrea Chief Accounting Officer | Grant or award | +5,817 | 69,905 | ||
| 2024-03-01 | Marshall Robert J. Jr. CFO and Treasurer | Grant or award | +36,547 | 139,717 | ||
| 2024-03-01 | Marshall Robert J. Jr. CFO and Treasurer | Grant or award · Stock Option (right to buy) | +21,652 | 21,652 | ||
| 2024-03-01 | Blanchfield Paul President | Grant or award | +36,547 | 125,198 | ||
| 2024-03-01 | Blanchfield Paul President | Grant or award · Stock Option (right to buy) | +21,652 | 21,652 | ||
| 2024-03-01 | Montagut Etienne Chief Business Officer | Grant or award | +31,326 | 98,580 | ||
| 2024-03-01 | Montagut Etienne Chief Business Officer | Grant or award · Stock Option (right to buy) | +18,559 | 18,559 | ||
| 2024-03-01 | Provost Jean-Claude Chief Medical Officer | Grant or award | +18,564 | 39,387 | ||
| 2024-03-01 | Provost Jean-Claude Chief Medical Officer | Grant or award · Stock Option (right to buy) | +10,998 | 10,998 | ||
| 2024-03-01 | Niedzwiecki Daniel See Remarks | Grant or award | +30,456 | 96,751 | ||
| 2024-03-01 | Niedzwiecki Daniel See Remarks | Grant or award · Stock Option (right to buy) | −18,043 | 18,043 | ||
| 2024-03-01 | MARKISON BRIAN A CEO | Grant or award | +131,496 | 152,826 | ||
| 2024-03-01 | Sabens Andrea Chief Accounting Officer | Grant or award | +5,685 | 64,088 | ||
| 2024-03-01 | Sabens Andrea Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +3,368 | 3,368 | ||
| 2024-02-13 | Sabens Andrea Chief Accounting Officer | Sale 10b5-1 | −341 | $55.31 | $19K | 58,403 |
| 2024-01-16 | Sabens Andrea Chief Accounting Officer | Sale 10b5-1 | −341 | $56.01 | $19K | 58,744 |
| 2023-12-15 | Marshall Robert J. Jr. CFO and Treasurer | Sale 10b5-1 | −10,000 | $78.24 | $782K | 103,170 |
| 2023-12-13 | Sabens Andrea Chief Accounting Officer | Sale 10b5-1 | −341 | $75.62 | $26K | 59,085 |
Page 12 of 19 · 376 trades